Clinical Trial Update: High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies [NA]

View source ↗

Summary

A clinical trial is evaluating high dose-rate brachytherapy for unresectable primary and metastatic liver malignancies. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma
• Melanoma
• Pancreatic Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Malignant Tumors, Cholangiocarcinoma Metastatic | NA | Status: RECRUITING